"New Study on ‘Breakthrough’ Atopic Dermatitis Drug Indicates ‘Eczema Is An Autoimmune Disease’"
Researchers behind a new study on the atopic dermatitis drug “dupilumab” (which is currently in trials) say that they have proven that this form of eczema is an autoimmune disease. The potential atopic dermatitis medication blocks the activity of two key immune proteins, interleukin-4 (IL-4) and interleukin-13 (IL-13), and according to the researchers, can reverse the immune response within an allergic individual that causes the atopic dermatitis skin problems. The promising new atopic dermatitis drug study was led by Emma Guttman-Yassky, MD, Associate Professor of Dermatology at the Icahn School of Medicine at Mount Sinai. Learn more.
Mount Sinai Launches the Marilyn Monroe Mental Health for the Arts Program
Apr 30, 2026 View All Press Releases
Mount Sinai’s Emma Guttman, MD, PhD, Elected to the Association of American Physicians
Apr 22, 2026 View All Press Releases
A Promising Study Suggests a Blood Test Could Spot Alzheimer’s Early in Progression
Apr 21, 2026 View All Press Releases